Del Carpio OL

Language: Spanish
References: 5
Page: 920-922
PDF size: 173.57 Kb.

ABSTRACT

This document exposes the current health problem in which, due to government policies, there is no adequate distribution of antiviral drugs to the population, despite having guidelines where the criteria for receiving them are established, as well as the medical units in the country that must grant them to the population. In the same way, a criticism is made of the vaccination policy in which monovalent vaccines that do not have verifiable efficacy before the omicron strains are preferred to be given to the population instead of bivalent vaccines that are fully indicated in this pandemic stage.

REFERENCES

1. Del Carpio-Orantes L. Los kits anti-COVID-19 ¿aportan algúnbeneficio a la lucha contra la pandemia? Med Int Mex 2022;38 (2): 425-427. https://doi.org/10.24245/mim.v38i2.5893.

2. Nava A. Retractan y acusan de engaño a artículo que sustentóel uso de ivermectina en pacientes con COVID-19 en México.https://espanol.medscape.com/verarticulo/5908522.

3. Lineamiento operativo en el uso de emergencia de Paxlovid® (Nirmatrelvir / ritonavir) en grupos de riesgo paraCOVID-19, en México 2022.

4. https://elpais.com/mexico/2022-09-25/la-vacuna-bivalente-que-actua-contra-la-covid-19-y-sus-variantes-nollegara-a-mexico.html.

5. https://www.informador.mx/ideas/Otra-vez-la-irresponsabilidad-20220704-0029.html.